Detailed Information
Cited 10 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Pembrolizumab with or without chemotherapy versus chemotherapy alone for patients with PD-L1-positive advanced gastric or gastroesophageal junction adenocarcinoma: Update from the phase 3 KEYNOTE-062 trial
- Authors
- Wainberg, ZA[Wainberg, Zev A.]; Shitara, K[Shitara, Kohei]; Van Cutsem, E[Van Cutsem, Eric]; Wyrwicz, L[Wyrwicz, Lucjan]; Lee, KW[Lee, Keun Wook]; Kudaba, I[Kudaba, Iveta]; Garrido, M[Garrido, Marcelo]; Chung, HCC[Chung, Hyun Cheol Cheol]; Lee, J[Lee, Jeeyun]; Castro-Salguero, HR[Castro-Salguero, Hugo Raul]; Mansoor, W[Mansoor, Wasat]; Braghiroli, MI[Braghiroli, Maria Ignez]; Karaseva, N[Karaseva, Nina]; Goekkurt, E[Goekkurt, Eray]; Satake, H[Satake, Hironaga]; Chao, J[Chao, Joseph]; Kher, U[Kher, Uma]; Shah, S[Shah, Sukrut]; Bhagia, P[Bhagia, Pooja]; Tabernero, J[Tabernero, Josep]
- Issue Date
- 1-Feb-2022
- Publisher
- LIPPINCOTT WILLIAMS & WILKINS
- Citation
- JOURNAL OF CLINICAL ONCOLOGY, v.40, no.4
- Indexed
- SCIE
SCOPUS
- Journal Title
- JOURNAL OF CLINICAL ONCOLOGY
- Volume
- 40
- Number
- 4
- ISSN
- 0732-183X
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Medicine > Department of Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.